Mirae Asset Global Investments’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.3K Sell
2,589
-428
-14% -$13.5K ﹤0.01% 1247
2026
Q1
$84.5K Buy
3,017
+218
+8% +$7.15K ﹤0.01% 1207
2025
Q4
$105K Buy
2,799
+575
+26% +$18.9K ﹤0.01% 1248
2025
Q3
$61.3K Buy
2,224
+6
+0.3% +$207 ﹤0.01% 1304
2025
Q2
$70.1K Buy
2,218
+299
+16% +$9.62K ﹤0.01% 1202
2025
Q1
$63.7K Buy
1,919
+19
+1% +$681 ﹤0.01% 1197
2024
Q4
$65K Sell
1,900
-156
-8% -$5.36K ﹤0.01% 1226
2024
Q3
$80.5K Buy
2,056
+360
+21% +$12.6K ﹤0.01% 1220
2024
Q2
$53.4K Sell
1,696
-11,256
-87% -$338K ﹤0.01% 1233
2024
Q1
$404K Sell
12,952
-3,610
-22% -$116K ﹤0.01% 1994
2023
Q4
$535K Buy
16,562
+52
+0.3% +$1.45K ﹤0.01% 1931
2023
Q3
$541K Buy
16,510
+55
+0.3% +$1.91K ﹤0.01% 1843
2023
Q2
$579K Buy
16,455
+3,717
+29% +$128K ﹤0.01% 1873
2023
Q1
$416K Sell
12,738
-30
-0.2% -$1.37K ﹤0.01% 2016
2022
Q4
$704K Buy
12,768
+278
+2% +$15.3K ﹤0.01% 1694
2022
Q3
$553K Buy
+12,490
New +$609K ﹤0.01% 1813

Other funds holding HRMY

Mirae Asset Global Investments's HRMY Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Harmony Biosciences (HRMY) stake by 14% in Q2 2026, selling an estimated $13.5K and leaving 2,589 shares worth $94.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1247.

Mirae Asset Global Investments first reported a position in HRMY in Q3 2022 and has held it in 16 quarters since. The position peaked at $704K in Q4 2022. 120 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Mirae Asset Global Investments held 2,589 shares of Harmony Biosciences worth $94.3K as of Q2 2026.
  • Mirae Asset Global Investments sold 428 Harmony Biosciences shares in Q2 2026, an estimated $13.5K.
  • Harmony Biosciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1247 holding.
  • Mirae Asset Global Investments first reported a position in Harmony Biosciences in Q3 2022 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Harmony Biosciences position peaked at $704K in Q4 2022.
  • 120 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.